AU783062B2 - Gastroretentive controlled release pharmaceutical dosage forms - Google Patents

Gastroretentive controlled release pharmaceutical dosage forms

Info

Publication number
AU783062B2
AU783062B2 AU16477/01A AU1647701A AU783062B2 AU 783062 B2 AU783062 B2 AU 783062B2 AU 16477/01 A AU16477/01 A AU 16477/01A AU 1647701 A AU1647701 A AU 1647701A AU 783062 B2 AU783062 B2 AU 783062B2
Authority
AU
Australia
Prior art keywords
delivery system
drug
polymer
matrix
stomach
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU16477/01A
Other languages
English (en)
Other versions
AU1647701A (en
Inventor
Michael Friedman
Amnon Hoffman
Eytan Klausner
Eran Lavy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yissum Research Development Co of Hebrew University of Jerusalem
Original Assignee
Yissum Research Development Co of Hebrew University of Jerusalem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Research Development Co of Hebrew University of Jerusalem filed Critical Yissum Research Development Co of Hebrew University of Jerusalem
Publication of AU1647701A publication Critical patent/AU1647701A/en
Application granted granted Critical
Publication of AU783062B2 publication Critical patent/AU783062B2/en
Priority to AU2005256098A priority Critical patent/AU2005256098A1/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU16477/01A 1999-11-29 2000-11-20 Gastroretentive controlled release pharmaceutical dosage forms Expired AU783062B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2005256098A AU2005256098A1 (en) 1999-11-29 2005-12-22 Gastroretentive controlled release pharmaceutical dosage forms

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL13319699A IL133196A0 (en) 1999-11-29 1999-11-29 Gastroretentive controlled release pharmaceutical dosage forms
IL133196 1999-11-29
PCT/IL2000/000774 WO2001037812A2 (en) 1999-11-29 2000-11-20 Gastroretentive controlled release pharmaceutical dosage forms

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2005256098A Division AU2005256098A1 (en) 1999-11-29 2005-12-22 Gastroretentive controlled release pharmaceutical dosage forms

Publications (2)

Publication Number Publication Date
AU1647701A AU1647701A (en) 2001-06-04
AU783062B2 true AU783062B2 (en) 2005-09-22

Family

ID=11073546

Family Applications (1)

Application Number Title Priority Date Filing Date
AU16477/01A Expired AU783062B2 (en) 1999-11-29 2000-11-20 Gastroretentive controlled release pharmaceutical dosage forms

Country Status (12)

Country Link
US (1) US6685962B2 (cg-RX-API-DMAC7.html)
EP (1) EP1235557B1 (cg-RX-API-DMAC7.html)
JP (1) JP4679020B2 (cg-RX-API-DMAC7.html)
AT (1) ATE300286T1 (cg-RX-API-DMAC7.html)
AU (1) AU783062B2 (cg-RX-API-DMAC7.html)
CA (1) CA2392361C (cg-RX-API-DMAC7.html)
DE (1) DE60021604T2 (cg-RX-API-DMAC7.html)
ES (1) ES2243327T3 (cg-RX-API-DMAC7.html)
IL (2) IL133196A0 (cg-RX-API-DMAC7.html)
RU (1) RU2002114348A (cg-RX-API-DMAC7.html)
WO (1) WO2001037812A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200204268B (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11529310B2 (en) 2020-12-08 2022-12-20 Ruminant Biotech Corp Limited Devices and methods for delivery of substances to animals

Families Citing this family (89)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040219186A1 (en) * 2001-08-16 2004-11-04 Ayres James W. Expandable gastric retention device
TWI312285B (en) * 2001-10-25 2009-07-21 Depomed Inc Methods of treatment using a gastric retained gabapentin dosage
AUPR951501A0 (en) * 2001-12-14 2002-01-24 Smart Drug Systems Inc Modified sustained release pharmaceutical system
US20040192582A1 (en) 2002-12-19 2004-09-30 Burnett Daniel R. Ingestible formulations for transient, noninvasive reduction of gastric volume
US7554452B2 (en) * 2003-07-18 2009-06-30 Cary Cole Ingestible tracking and locating device
JP4988345B2 (ja) * 2003-09-04 2012-08-01 ザ・ユナイテッド・ステイツ・オブ・アメリカ・アズ・リプレゼンティッド・バイ・ザ・デパートメント・オブ・ヴェテランズ・アフェアーズ 眼用ハイドロゲルナノコンポジット
JP2007507491A (ja) * 2003-09-29 2007-03-29 シージェー コーポレーション 徐放性製剤
CA2549195A1 (en) * 2003-12-09 2005-06-23 Spherics, Inc. Bioadhesive polymers with catechol functionality
US20080089933A1 (en) * 2006-10-16 2008-04-17 Amir Alon Device and method for reducing calorie intake
US20050196355A1 (en) * 2004-03-03 2005-09-08 Constantine Georgiades Film products having controlled disintegration properties
US8007827B2 (en) * 2004-04-02 2011-08-30 Impax Laboratories, Inc. Pharmaceutical dosage forms having immediate release and/or controlled release properties
US8226977B2 (en) 2004-06-04 2012-07-24 Teva Pharmaceutical Industries Ltd. Pharmaceutical composition containing irbesartan
US20080311191A1 (en) * 2004-08-27 2008-12-18 Avinash Nangia Multi-Layer Tablets and Bioadhesive Dosage Forms
CA2592605C (en) * 2004-12-27 2010-12-07 Eisai R&D Management Co., Ltd. Method for stabilizing anti-dementia drug
US20070129402A1 (en) * 2004-12-27 2007-06-07 Eisai Research Institute Sustained release formulations
US20060246003A1 (en) * 2004-12-27 2006-11-02 Eisai Co. Ltd. Composition containing anti-dementia drug
US20060280789A1 (en) * 2004-12-27 2006-12-14 Eisai Research Institute Sustained release formulations
IL166183A0 (en) * 2005-01-06 2006-01-15 Yissum Res Dev Co Novel diagnostic and imaging techniques of the gi tract
KR100822519B1 (ko) * 2005-02-15 2008-04-16 주식회사종근당 위장 내에서 제어방출되는 단일 매트릭스 정제
EP1933811A2 (en) * 2005-09-30 2008-06-25 Alza Corporation Banded controlled release nanoparticle active agent formulation dosage forms and methods
US20070092565A1 (en) * 2005-10-25 2007-04-26 Pharmascience Inc. Gastric retention drug delivery system
TR201902010T4 (tr) 2006-01-18 2019-03-21 Intec Pharma Ltd Bir ajanın oral alımına yönelik taşıyıcı cihaz.
WO2007093999A1 (en) * 2006-02-15 2007-08-23 Intec Pharma Ltd. A gastro-retentive system for the delivery of macromolecules
WO2007103286A2 (en) * 2006-03-02 2007-09-13 Spherics, Inc. Rate-controlled bioadhesive oral dosage formulations
US20080139655A1 (en) * 2006-09-08 2008-06-12 Drugtech Corporation Sustained-release composition and method of use thereof
ZA200904573B (en) 2006-12-22 2010-09-29 Ironwood Pharmaceuticals Inc Compositions comprising bile acid sequestrants for treating esophageal disorders
WO2008115597A2 (en) * 2007-03-21 2008-09-25 Cytologic, Inc. Cytokine muteins and methods for enhancing immune responses in mammals
PT2192946T (pt) 2007-09-25 2022-11-17 Otsuka Pharma Co Ltd Dispositivo no corpo com amplificação de sinal dipolo virtual
ES2463774T3 (es) 2007-11-12 2014-05-29 Pharmaceutics International, Inc. Complejos trimoleculares y su uso en sistemas de administración de fármacos
EP2276473B1 (en) * 2008-04-18 2016-09-14 Intec Pharma Ltd. Gastroretentive drug delivery for carbidopa/levodopa
US7981760B2 (en) * 2008-05-08 2011-07-19 Panasonic Corporation Method for manufacturing nonvolatile storage element and method for manufacturing nonvolatile storage device
US8287902B2 (en) * 2008-07-23 2012-10-16 Rainbow Medical Ltd. Enhanced-diffusion capsule
WO2010064139A2 (en) * 2008-12-04 2010-06-10 Intec Pharma Ltd. Zaleplon gastroretentive drug delivery system
US9901551B2 (en) 2009-04-20 2018-02-27 Ambra Bioscience Llc Chemosensory receptor ligand-based therapies
US8828953B2 (en) * 2009-04-20 2014-09-09 NaZura BioHealth, Inc. Chemosensory receptor ligand-based therapies
JP2012524125A (ja) 2009-04-20 2012-10-11 エルセリクス セラピューティクス インコーポレイテッド 化学感覚受容体リガンドに基づく治療法
US8414559B2 (en) * 2009-05-07 2013-04-09 Rainbow Medical Ltd. Gastroretentive duodenal pill
US20100286628A1 (en) * 2009-05-07 2010-11-11 Rainbow Medical Ltd Gastric anchor
US20110066175A1 (en) * 2009-05-07 2011-03-17 Rainbow Medical Ltd. Gastric anchor
WO2011048494A2 (en) * 2009-10-19 2011-04-28 Intec Pharma Ltd. Novel gastroretentive dosage forms of poorly soluble drugs
CA2780294C (en) 2009-11-09 2018-01-16 Spotlight Technology Partners Llc Polysaccharide based hydrogels
CN107033368A (zh) 2009-11-09 2017-08-11 聚光灯技术合伙有限责任公司 碎裂水凝胶
JP5753187B2 (ja) 2009-12-18 2015-07-22 ヴィセラ・バイオメディカル・リミテッド 医用生体材料
WO2011073968A1 (en) * 2009-12-18 2011-06-23 Vysera Biomedical Limited A drug delivery system
EP2544666A2 (en) 2010-03-09 2013-01-16 Council of Scientific and Industrial Research Gastroretentive, extended release composition of therapeutic agent
US10010439B2 (en) 2010-06-13 2018-07-03 Synerz Medical, Inc. Intragastric device for treating obesity
US9526648B2 (en) 2010-06-13 2016-12-27 Synerz Medical, Inc. Intragastric device for treating obesity
US8628554B2 (en) 2010-06-13 2014-01-14 Virender K. Sharma Intragastric device for treating obesity
US10420665B2 (en) 2010-06-13 2019-09-24 W. L. Gore & Associates, Inc. Intragastric device for treating obesity
US20130156720A1 (en) 2010-08-27 2013-06-20 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
SG189444A1 (en) 2010-10-19 2013-05-31 Elcelyx Therapeutics Inc Chemosensory receptor ligand-based therapies
HRP20201731T1 (hr) 2011-01-07 2020-12-25 Anji Pharma (Us) Llc Terapije na bazi liganda kemozensoričkog receptora
US8722066B2 (en) 2011-03-29 2014-05-13 Primigenia, LLC Devices and methods for weight control and weight loss
US20130143867A1 (en) 2011-12-02 2013-06-06 Sychroneuron Inc. Acamprosate formulations, methods of using the same, and combinations comprising the same
WO2013158928A2 (en) 2012-04-18 2013-10-24 Elcelyx Therapeutics, Inc. Chemosensory receptor ligand-based therapies
WO2014039951A1 (en) 2012-09-10 2014-03-13 Novartis Ag Enteral pharmaceutical compositions
US9682081B2 (en) 2013-04-25 2017-06-20 Sun Pharmaceutical Industries Limited Pharmaceutical gastro-retentive solid oral dosage form of nilotinib
US10166207B2 (en) 2013-06-05 2019-01-01 Synchroneuron, Inc. Acamprosate formulations, methods of using the same, and combinations comprising the same
EP3083031B1 (en) * 2013-12-20 2019-10-16 Fresenius Kabi Deutschland GmbH Microcapsules with polymeric coating comprising a lipid and an active agent
CN106535878B (zh) 2014-06-02 2022-11-01 科莱西奥生物科技有限公司 可张开的胃内滞留剂型
CN106573999A (zh) 2014-06-11 2017-04-19 麻省理工学院 驻留结构及相关方法
US20170266112A1 (en) 2014-06-11 2017-09-21 Massachusetts Institute Of Technology Residence structures and related methods
US9492396B2 (en) 2014-07-15 2016-11-15 Yossi Gross Enhanced drug delivery pill
CN206120771U (zh) * 2015-06-03 2017-04-26 南京三迭纪医药科技有限公司 药品剂型
EP3302442B1 (en) * 2015-06-03 2024-10-16 Triastek, Inc. Dosage forms and use thereof
MA42196A (fr) 2015-06-17 2018-04-25 Biogen Ma Inc Particules de fumarate de diméthyle et leurs compositions pharmaceutiques
WO2017070612A1 (en) 2015-10-23 2017-04-27 Lyndra, Inc. Gastric residence systems for sustained release of therapeutic agents and methods of use thereof
US11129798B2 (en) 2016-08-19 2021-09-28 Aron H. Blaesi Fibrous dosage form
US11478427B2 (en) * 2015-10-26 2022-10-25 Aron H. Blaesi Dosage form comprising structural framework of two-dimensional elements
EP3368010B1 (en) * 2015-10-26 2025-12-10 Blaesi, Aron H. Solid dosage form immediate drug release and apparatus and method for manufacture thereof
CN108601724A (zh) * 2015-12-01 2018-09-28 克雷西奥生物科技有限公司 胃滞留装置
CA3007165A1 (en) * 2015-12-02 2017-06-08 Clexio Biosciences Ltd. Device for preparing gastroretentive dosage forms
ES2963058T3 (es) 2015-12-08 2024-03-25 Lyndra Therapeutics Inc Configuraciones geométricas para sistemas de residencia gástrica
CA3017797A1 (en) 2016-03-17 2017-09-21 Thiogenesis Therapeutics, Inc. Compositions for controlled release of cysteamine and systemic treatment of cysteamine sensitive disorders
US10779980B2 (en) 2016-04-27 2020-09-22 Synerz Medical, Inc. Intragastric device for treating obesity
US12109305B2 (en) 2016-05-27 2024-10-08 Lyndra Therapeutics, Inc. Materials architecture for gastric residence systems
SG11201811209QA (en) * 2016-07-11 2019-01-30 Intec Pharma Ltd Oral gastroretentive formulations and uses thereof
WO2018064630A1 (en) 2016-09-30 2018-04-05 Lyndra, Inc. Gastric residence systems for sustained delivery of adamantane-class drugs
CN110035718B (zh) 2016-12-02 2021-04-06 克雷西奥生物科技有限公司 胃内滞留系统
WO2018137686A1 (en) 2017-01-26 2018-08-02 Triastek, Inc. Dosage forms of controlled release at specific gastrointestinal sites
US12023406B2 (en) 2017-06-09 2024-07-02 Lyndra Therapeutics, Inc. Gastric residence systems with release rate-modulating films
ES3024932T3 (en) 2017-09-20 2025-06-05 Thiogenesis Therapeutics Inc Compounds for the treatment of cysteamine sensitive disorders
US11547839B2 (en) 2017-12-04 2023-01-10 Clexio Biosciences Ltd. Long acting gastric residence system
CN116270513A (zh) 2018-01-09 2023-06-23 南京三迭纪医药科技有限公司 一种包含固定剂量adhd非兴奋剂和adhd兴奋剂的复方口服药物剂型
CN114191307A (zh) 2020-09-17 2022-03-18 上海汉都医药科技有限公司 一种口腔滞留装置及其制备方法
WO2019223753A1 (zh) 2018-05-23 2019-11-28 上海汉都医药科技有限公司 活性药物成分的控释系统及其制备方法
US11911513B2 (en) 2018-05-23 2024-02-27 Shanghai Wd Pharmaceutical Co., Ltd Controlled-release system of active pharmaceutical ingredient and preparation method therefor
US10675248B2 (en) 2018-08-14 2020-06-09 Alma Therapeutics Ltd. Expandable pill
WO2022245913A1 (en) 2021-05-20 2022-11-24 E Ink California, Llc Benefit agent delivery system using electroplating

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5002772A (en) * 1988-05-31 1991-03-26 Pfizer Inc. Gastric retention system for controlled drug release
EP0656204A1 (en) * 1993-11-30 1995-06-07 EKITA Investments N.V. Controlled release pharmaceutical tablet having lenticular form
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3574820A (en) 1968-01-08 1971-04-13 Upjohn Co Medicinal dosage forms of unpolymerized thiolated gelatin with a cross-linking accelerating agent providing slowly released medication from a swollen matrix
US4207890A (en) 1977-01-04 1980-06-17 Mcneilab, Inc. Drug-dispensing device and method
US4434153A (en) 1982-03-22 1984-02-28 Alza Corporation Drug delivery system comprising a reservoir containing a plurality of tiny pills
US4735804A (en) 1985-05-10 1988-04-05 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
US4758436A (en) 1985-05-29 1988-07-19 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
US4767627A (en) 1985-05-29 1988-08-30 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
US5217712A (en) 1989-09-20 1993-06-08 Merck & Co., Inc. Bioerodible thermoset elastomers
US5047464A (en) 1989-09-20 1991-09-10 Merck & Co., Inc. Bioerodible thermoset elastomers
DE4406424A1 (de) 1994-02-28 1995-08-31 Bayer Ag Expandierbare Arzneiformen

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5002772A (en) * 1988-05-31 1991-03-26 Pfizer Inc. Gastric retention system for controlled drug release
EP0656204A1 (en) * 1993-11-30 1995-06-07 EKITA Investments N.V. Controlled release pharmaceutical tablet having lenticular form
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11529310B2 (en) 2020-12-08 2022-12-20 Ruminant Biotech Corp Limited Devices and methods for delivery of substances to animals
US12128134B2 (en) 2020-12-08 2024-10-29 Ruminant Biotech Corp Limited Devices and methods for delivery of substances to animals
US12171873B2 (en) 2020-12-08 2024-12-24 Ruminant Biotech Corp Limited Devices and methods for delivery of substances to animals

Also Published As

Publication number Publication date
RU2002114348A (ru) 2004-01-10
US6685962B2 (en) 2004-02-03
JP2003514845A (ja) 2003-04-22
IL149853A (en) 2006-12-31
EP1235557A2 (en) 2002-09-04
ZA200204268B (en) 2003-08-28
US20030021845A1 (en) 2003-01-30
ES2243327T3 (es) 2005-12-01
DE60021604D1 (de) 2005-09-01
WO2001037812A3 (en) 2002-02-21
WO2001037812A2 (en) 2001-05-31
IL133196A0 (en) 2001-03-19
ATE300286T1 (de) 2005-08-15
CA2392361A1 (en) 2001-05-31
JP4679020B2 (ja) 2011-04-27
AU1647701A (en) 2001-06-04
EP1235557B1 (en) 2005-07-27
CA2392361C (en) 2010-01-19
DE60021604T2 (de) 2006-06-01

Similar Documents

Publication Publication Date Title
AU783062B2 (en) Gastroretentive controlled release pharmaceutical dosage forms
KR101601649B1 (ko) 카르비도파／레보도파 위체류 약물 전달
Dehghan et al. Gastroretentive drug delivery systems: A patent perspective
Arunachalam et al. Floating drug delivery systems: A review
US20060045865A1 (en) Controlled regional oral delivery
US20080026040A1 (en) Active agent-releasing dosage forms
JP2019196396A (ja) 薬剤の活性剤をｉｎ−ｓｉｔｕ放出させるための滞留装置及びシステム
EP2061438A1 (en) Extended release gastro-retentive oral drug delivery system for valsartan
KR20030013460A (ko) 치료제의 위 체류 및 방출 조절을 위한 급속 팽창성조성물과 이 조성물을 포함하는 제형
Shashank et al. Approaches to increase the gastric residence time: floating drug delivery systems-a review
CN101453993A (zh) 含有机溶胶涂层的受控释放递送物件
PL207776B1 (pl) Kompozycja farmaceutyczna o zmodyfikowanym uwalnianiu
EP2378883A2 (en) Zaleplon gastroretentive drug delivery system
WO1998027967A1 (en) Release-controlled coated tablets
CA2851765A1 (en) A gastroretentive dosage system and process of preparation thereof
Bikiaris et al. New aspects in sustained drug release formulations
AU2005256098A1 (en) Gastroretentive controlled release pharmaceutical dosage forms
Tamizharasi et al. Floating drug delivery system.
Rajak et al. Gastroretentive floating drug delivery system: an approach in gastroretentive drug delivery
Dabholkar et al. Advanced solid oral controlled-release formulations
Katakam et al. Floating Drug Delivery Systems: A Review.
Patel et al. Gastro-retentive drug delivery systems: Modern insights on approaches and applications
Pancholi Formulation approaches to enhance the bioavailability of narrow absorption window drugs
Patel et al. International Journal of Gastrointestinal Intervention
WO2000016784A1 (en) Oral drug delivery system for enhancing the bioavailability of activated glycyrrhetin

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired